Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

LV305, a dendritic cell-targeting integration-deficient ZVex(TM)-based lentiviral vector encoding NY-ESO-1, induces potent anti-tumor immune response.

Albershardt TC, Campbell DJ, Parsons AJ, Slough MM, Ter Meulen J, Berglund P.

Mol Ther Oncolytics. 2016 Mar 30;3:16010. doi: 10.1038/mto.2016.10. eCollection 2016.

2.

Design of a titering assay for lentiviral vectors utilizing direct extraction of DNA from transduced cells in microtiter plates.

Murphy ME, Vin CD, Slough MM, Gombotz WR, Kelley-Clarke B.

Mol Ther Methods Clin Dev. 2016 Feb 17;3:16005. doi: 10.1038/mtm.2016.5. eCollection 2016.

3.

Virological and preclinical characterization of a dendritic cell targeting, integration-deficient lentiviral vector for cancer immunotherapy.

Odegard JM, Kelley-Clarke B, Tareen SU, Campbell DJ, Flynn PA, Nicolai CJ, Slough MM, Vin CD, McGowan PJ, Nelson LT, Ter Meulen J, Dubensky TW Jr, Robbins SH.

J Immunother. 2015 Feb-Mar;38(2):41-53. doi: 10.1097/CJI.0000000000000067.

4.

Design of a novel integration-deficient lentivector technology that incorporates genetic and posttranslational elements to target human dendritic cells.

Tareen SU, Kelley-Clarke B, Nicolai CJ, Cassiano LA, Nelson LT, Slough MM, Vin CD, Odegard JM, Sloan DD, Van Hoeven N, Allen JM, Dubensky TW Jr, Robbins SH.

Mol Ther. 2014 Mar;22(3):575-587. doi: 10.1038/mt.2013.278. Epub 2013 Dec 6.

5.

A Rev-Independent gag/pol Eliminates Detectable psi-gag Recombination in Lentiviral Vectors.

Tareen SU, Nicolai CJ, Campbell DJ, Flynn PA, Slough MM, Vin CD, Kelley-Clarke B, Odegard JM, Robbins SH.

Biores Open Access. 2013 Dec 1;2(6):421-30. doi: 10.1089/biores.2013.0037.

6.

Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease.

Marder K, Gu Y, Eberly S, Tanner CM, Scarmeas N, Oakes D, Shoulson I; Huntington Study Group PHAROS Investigators.

JAMA Neurol. 2013 Nov;70(11):1382-8. doi: 10.1001/jamaneurol.2013.3487.

7.

Dietary intake in adults at risk for Huntington disease: analysis of PHAROS research participants.

Marder K, Zhao H, Eberly S, Tanner CM, Oakes D, Shoulson I; Huntington Study Group.

Neurology. 2009 Aug 4;73(5):385-92. doi: 10.1212/WNL.0b013e3181b04aa2.

8.

Some medicolegal aspects of anesthesiology.

SLOUGH MC.

Postgrad Med. 1959 Jan;25(1):A-36 passim. No abstract available.

PMID:
13614068

Supplemental Content

Loading ...
Support Center